1. bookVolume 21 (2013): Issue 3 (September 2013)
Journal Details
License
Format
Journal
eISSN
2284-5623
ISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Open Access

The importance of the new prognostic scoring system for evaluating patients with lower-risk myelodysplastic syndrome at diagnosis

Journal Details
License
Format
Journal
eISSN
2284-5623
ISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol, 1982, 51:189-199.10.1111/j.1365-2141.1982.tb08475.xSearch in Google Scholar

2. Cazzola M, Malcovati L: Myelodysplastic syndromes -coping with ineffective hematopoiesis. N Engl J Med, 2005, 352: 536-538.10.1056/NEJMp04826615703418Search in Google Scholar

3. Vardiman JW, Harris NL, Brunning RD: The new World Health Organization classification of myeloid neoplasms: Blood, 2002, 100:2292-2302.10.1182/blood-2002-04-119912239137Search in Google Scholar

4. Fenaux P: Myelodysplastic syndromes: from pathogenesis and prognosis to treatment. SeminHematol., 2004;41:6-12.10.1053/j.seminhematol.2004.02.00215190510Search in Google Scholar

5. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G: International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes. Blood, 1997; 89:2079-2088.10.1182/blood.V89.6.2079Search in Google Scholar

6. Greenberg P, Tuechler H, Schanz J, Sanz G, Solé F, Bennett J et al: Revised International Prognostic Scoring System for Myelodysplastic Syndromes. Blood, 2012 120: 2454-2465.10.1182/blood-2012-03-420489442544322740453Search in Google Scholar

7. Swansbury J: Methods in Molecular Biology TMCancer Cytogenetics Methods and Protocols.Humana, 2003;220: 43-56.Search in Google Scholar

8. Shaffer LG, Slovak ML, Campbell JL: An International System for Human Cytogenetic Nomenclature, 2009.Search in Google Scholar

9. Nowell PC. Chromosome abnormalities in myelodysplastic syndromes. SeminOncol, 1992;19:1925-1929.Search in Google Scholar

10. Haase D, Germing U, Schanz J, Pfeilstöcker M, Nösslinger T, Steidl N: New insights into the prognostic impact of the karyotype in MDS andcorrelation with subtypes: evidence from a core dataset of 2124 patients. Blood 2007, 110: 4385-439510.1182/blood-2007-03-08240417726160Search in Google Scholar

11. De Witte T, Hermans J, Vossen J, Bacigalupo A., Meloni G., Jacobsen N. et al:Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukemias: A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).Br J Haematol,2000;110:620-630.10.1046/j.1365-2141.2000.02200.x10997974Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo